etesevimab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for etesevimab, covering 2021-03-11 to 2024-12-13. Get the full timeline:
Most recent: EMA Withdrawn from rolling review: Bamlanivimab and etesevimab for COVID-19 (bamlanivimab;Etesevimab) — Eli Lilly Nederland B.V.